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Eicosapentaenoic acid (EPA), one of the n-3 polyunsaturated fatty
acids, has been shown to stimulate leptin mRNA expression and
secretion in 3T3-L1 cells. However, other studies have reported
inhibitory effects of EPA on leptin expression and secretion in vivo
and in vitro. To determine the direct effects of EPA on basal and
insulin-stimulated leptin secretion, isolated rat adipocytes were incu-
bated with EPA in the absence and presence of insulin. EPA (10, 100,
and 200 M) increased basal leptin gene expression and secretion
(43.8%, P  0.05; 71.1%, P  0.01; and 73.7%, P  0.01,
respectively). EPA also increased leptin secretion in the presence of
1.6 nM insulin; however, the effect was less pronounced than in the
absence of it. Because adipocyte glucose and lipid metabolism are
involved in the regulation of leptin production, the metabolic effects
of this fatty acid were also examined. EPA (200 M) increased basal
glucose uptake in isolated adipocytes (50%, P  0.05). Anaerobic
metabolism of glucose, as assessed by lactate production and propor-
tion of glucose metabolized to lactate, has been shown to be inversely
correlated to leptin secretion and was decreased by EPA in both the
absence and presence of insulin. EPA increased basal glucose oxida-
tion as determined by the proportion of 14C-labeled glucose metabo-
lized to CO2. Lipogenesis (14C-labeled glucose incorporation into
triglyceride) was decreased by EPA in the absence of insulin, whereas
lipolysis (glycerol release) was unaffected. The EPA-induced increase
of basal leptin secretion was highly correlated with increased glucose
utilization (r  0.89, P  0.01) and inversely related to the
anaerobic glucose metabolism to lactate. EPA’s effect on insulin-
stimulated leptin secretion was not related to increased glucose
utilization but was inversely correlated with anaerobic glucose me-
tabolism to lactate (r  0.84, P  0.01). Together, the results
suggest that EPA, like insulin, stimulates leptin production by increas-
ing the nonanaerobic/oxidative metabolism of glucose.
-3 polyunsaturated fatty acids; obesity; adipose tissue; diabetes
DIETARY FAT IS AN IMPORTANT macronutrient in the diet of all
animals (24). A growing body of literature suggests that the
amount (7) and type (6, 20, 48) of fat included in the diet have
roles in the development of obesity and insulin resistance.
Specifically, diets high in saturated fat promote obesity and
insulin resistance in rodents (25, 40), whereas diets high in fish
oil appear to prevent or attenuate the development of these
diseases (53). n-3 Polyunsaturated fatty acids (n-3 PUFAs)
present in fish oil are known to have numerous beneficial
effects on health (9, 13, 51). These include improvement of
endothelial function, anti-arrhythmic effects, reductions in
platelet aggregation and serum triglyceride concentrations
(10), and amelioration of pathological conditions such as
inflammatory diseases (23) and hypertension (39). Diets con-
taining high levels of n-3 PUFAs have been shown to reduce
white adipose tissue (3, 42) and adipocyte size (42, 43) and to
prevent non-insulin-dependent diabetes in rats (27, 28, 38, 53).
Indeed, eicosapentaenoic acid (EPA) [20:5 (n-3)], one of the
prominent n-3 PUFAs contained in fish oil, has been reported
to be useful in preventing the onset of insulin resistance and
diabetes in animal models of obesity and diabetes (32, 33, 38).
The results of several studies support the hypothesis that
alterations in the insulin sensitivity and metabolic activity of
adipocytes have critical roles in the development of insulin
resistance and type 2 diabetes in rodents (4).
Leptin is a hormone primarily secreted by white adipose
tissue, which has been implicated in the regulation of food
intake, energy expenditure, body fat stores, and insulin signal-
ing (16, 44). Circulating leptin concentrations are correlated
with adiposity in humans (14, 17) and animals (1); however,
these are also altered independently of changes of body adi-
posity by fasting and refeeding (15). Numerous studies indicate
that leptin production is increased by insulin (2, 56) and
therefore is modulated by insulin responses to meals and
dietary macronutrient composition (16, 19, 54). The effect of
insulin to increase leptin expression and secretion (34) and the
transcriptional activity of the leptin promoter (31) are mediated
by insulin’s effects to increase adipocyte glucose utilization.
Furthermore, insulin shifts glucose metabolism from anaerobic
metabolism to lactate to mitochondrial oxidation, and this
effect may contribute to insulin-mediated leptin production,
since anaerobic glucose metabolism does not increase leptin
secretion (35).
EPA has been reported to stimulate leptin gene expression
and secretion in 3T3-L1 adipocytes (37). In contrast, Reseland
et al. (47) reported that dietary n-3 PUFAs decreased leptin
mRNA expression in vivo and in vitro. To further address these
conflicting results, we examined the effects of EPA on the
leptin expression and secretion in primary cultures of isolated
rat adipocytes. Adipocytes were maintained for 96 h anchored
to a collagen matrix, which simulates basement membrane
attachment, producing a more physiological environment and
maintaining adipocyte differentiation compared with “free-
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floating” adipocytes (34). Little is known about the effects of
EPA on adipocyte metabolism (glucose and lipid metabolism),
which has been demonstrated to be involved in the regulation
of leptin production (34). Therefore, we also determined the
effects of EPA on basal and insulin-stimulated adipocyte glu-
cose utilization, lactate production, glucose oxidation, lipogen-
esis, and lipolysis.
MATERIALS AND METHODS
Materials. Media (DMEM), minimal essential medium amino ac-
ids, penicillin/streptomycin, fetal bovine serum, and nystatin were
purchased from GIBCO (Grand Island, NY) and Invitrogen Life
Technologies (Carlsbad, CA). BSA fraction V, HEPES, and insulin
were from Sigma (St. Louis, MO). Collagen (Vitrogen 100) was
purchased from Cohesion Technologies (Palo Alto, CA). [14C]glucose
was obtained from Perkin Elmer Life Sciences (Boston, MA). Type I
collagenase was purchased from Worthington Biochemical (Lake-
wood, NJ), and EPA was from Cayman Chemical.
Animals. Male Wistar rats (250–280 g of weight) were obtained
from the Applied Pharmacobiology Center (CIFA-Spain). The ani-
mals were housed in cages in temperature-controlled rooms (22 
2°C) with a 12:12-h light-dark cycle. All experimental procedures
were performed according to National and Institutional Guidelines for
Animal Care and Use and after the approval of the Ethical Committee
for Animal Care and Use at the University of Navarra. Animals were
euthanized, and epididymal adipose tissue was removed.
Adipocyte isolation and culture. Adipocytes were isolated from
epididymal fat depots. Fat was minced with scissors in HEPES buffer
(pH 7.4; containing 5 mM D-glucose, 2% BSA, 135 mM NaCl, 2.2
mM CaCl2 2H2O, 1.25 mM MgSO4 7H2O, 0.45 mM KH2PO4, 2.17
mM Na2HPO4, and 10 mM HEPES). Adipose tissue fragments were
digested in the same buffer with type I collagenase (1.25 mg/ml per
0.5 g tissue) at 37°C with gentle shaking for 30 min. The resulting cell
suspension was diluted in HEPES-phosphate buffer, and the isolated
adipocytes were then separated from the undigested tissue by filtration
through a 400-m nylon mesh and washed three times. Isolated
adipocytes were then resuspended in DMEM supplemented with 1%
FBS and incubated for 40 min at 37°C. The isolated adipocytes (150
l of 2:1 ratio of packed cells to medium) were then plated on 500 l
of a collagen matrix (Vitrogen 100, Cohesion Technologies) in six-
well culture plates. After 50 min of incubation at 37°C, the culture
media containing 0 or 1.6 nM insulin and the different concentrations
(0, 0.1, 1, 10, 100, 200 M) of the assayed EPA were added. Cells
were maintained in an incubator at 37°C in 5% CO2 for up to 96 h.
Aliquots (300 l) of the media were collected at 24, 48, 72, and 96 h
and replaced with fresh medium containing the appropriate concen-
tration of insulin and/or EPA.
Assays. Leptin concentrations in the media samples were deter-
mined by a radioimmunoassay for rat leptin (Linco Research, St.
Charles, MO), as previously described (26). Glucose and lactate were
measured with an Autoanalyzer (Cobas Roche Diagnostic, Basel,
Switzerland) (29).
Analyses of mRNA. Leptin mRNA levels were determined by
Northern blotting. The leptin cDNA probe was a 388-bp fragment of
mouse leptin cDNA, which was kindly provided by Dr. Charles
Mobbs (Mount Sinai School of Medicine, New York, NY). The 18S
ribosomal probe was obtained from Ambion (Austin, TX). RNA was
extracted according to the GIBCO-Life Technologies procedure with
the use of Trizol. The ultraviolet absorbance and integrity gels were
used to estimate RNA. Leptin and 18S cDNA probes were labeled by
random priming (Rediprime kit, Amersham, Buckinghamshire, UK)
in the presence of [32P]dCTP (3,000 Ci/mmol, Amersham). We
removed unincorporated nucleotides using NucTrap probe purifica-
tion columns (Stratagene, La Jolla, CA). For each tissue sample, 7 g
of total RNA were fractionated by electrophoresis on a denaturing 1%
agarose gel containing 2.2 M formaldehyde and 1 MOPS running
buffer. One microliter of a 50 g/ml ethidium bromide (GIBCO BRL,
Gaithersburg, MD) stock solution was added to check RNA integrity
and even loading. After electrophoresis, RNA was transferred to
nylon membrane (Duralon-UV, Stratagene) by overnight capillary
transfer and ultraviolet cross linked (Stratalinker 1800, Stratagene).
Blots were then hybridized for 1 h at 68°C in the presence of the
labeled cDNA probe (2  106 cpm/ml Express Hyb solution, Clon-
tech, Palo Alto, CA, and 1  106 cpm/ml with the 18S cDNA probe).
After blots were washed at high stringency, they were exposed to
X-ray films with an intensifying screen at80°C. To allow loading of
equal masses of RNA in each well, after analysis of leptin mRNA
using a single-stranded cDNA probe followed by quantification of
bands from film, we reanalyzed the blots using a probe complemen-
tary to mouse 18S ribosomal RNA. Leptin mRNA was then normal-
ized with respect to the 18S ribosomal signal.
Glucose incorporation into triglyceride. Glucose incorporation into
triglyceride was measured after 96 h of culture by counting the
14C-radiolabeled glucose incorporated into the adipocytes (52).
Throughout the culture, the adipocytes were incubated in media
containing 0.01 Ci/ml of [14C]glucose. After 96 h, the medium was
removed, along with any extracellular triglyceride in the wells, and 4
ml of methanol were added to each well. The adipocytes anchored into
the collagen and methanol were then transferred into a 50-ml glass
tube with screw cap. We washed the well again using an additional 1
ml of methanol, which was also transferred to the tube. Ten milliliters
of chloroform were added to each tube to extract the triglyceride as
described by Folch et al. (11). Twenty-four hours later, the tube was
filled with deionized water to separate the methanol from the chloro-
form containing the triglyceride. The water-methanol layer was aspi-
rated, and the remaining moisture was absorbed by addition of 4 g of
sodium sulfate. One milliliter of the chloroform-triglyceride was
pipetted into a scintillation vial, and radioactivity (dpm) was counted.
Five milliliters of the chloroform-lipid was pipetted into preweighed
aluminum pans. The chloroform was allowed to evaporate, and the
pan was weighed again to determine the retained triglyceride (mg).
Glucose oxidation. We measured glucose oxidation using a mod-
ification of the method of Rodbell (49) and based on the culture
system described by Bottcher and Furst (5). Briefly, cells isolated
from rat epididymal adipose tissue were plated in 25-ml glass scin-
tillation vials on 0.3 ml of collagen and 2 ml of medium containing
different concentrations of EPA. The vials were loosely covered with
a sheet of aluminum foil and incubated in a 37°C incubator (5% CO2).
After 48 h, 0.5 ml of medium was sampled from each vial and 0.5 ml
of treatment medium, which contained 0.12 Ci/ml of the [14C]glu-
cose, was added. Vials were capped with a rubber stopper that had
been fitted with a polystyrene hanging well containing a strip of
Whatman filter paper. Vials were gassed with 5% CO2 for 5 s using
vent/delivery needles. After 48 h of incubation, we sampled media
using a long needle and syringe, and benzethonium hydroxide was
placed onto the paper strips and hanging well to capture CO2.
Concentrated sulfuric acid was added to the vials to lyse cells and
liberate all CO2 from the collagen matrix. After an overnight period,
the hanging well and paper were transferred to another vial containing
scintillation fluid and counted in a 	-counter.
Lipolysis. Lipolysis was assessed by measuring glycerol released
into the media at 96 h. We determined glycerol using an Autoanalyzer
following the manufacturer’s instructions (Cobas Roche Diagnostic).
Data analyses. Glucose utilization was assessed by measuring the
concentration of glucose in the medium in each well at 24, 48, 72, and
96 h. Lactate production was calculated as the increase of lactate in
the medium at 24, 48, 72, and 96 h. The amount of carbon released as
lactate per amount of carbon taken up as glucose over 96 h was
calculated as 
[lactate]/
[glucose], where 
 is the difference, and
expressed as a percentage. The amount of glucose incorporated to
CO2 was calculated as (dpm collected on Whatman 1 strip)(total
glucose)/total dpm and expressed as a percentage of total glucose
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utilized. The amount of glucose incorporated into lipid was calculated
as [(dpm extracted in 1 ml of chloroform)(total glucose)/total dpm] 
10 ml of chloroform. This value was normalized over the amount of
total lipid recovered from the well and expressed as a percentage of
total glucose utilized.
Because of the high variability in basal leptin secretion between
adipocyte cultures from different rats, the experimental results from
each adipocyte suspension prepared from a single animal were ana-
lyzed in relation to a control well from the same suspension. For this
reason, the statistical analysis of the data was performed by a repeated-
measures ANOVA followed by a Dunnet’s posttest or by a paired
Student’s t-test (GraphPad Prism, GraphPad Software, San Diego,
CA). Results were also analyzed and expressed as the percentage of
the control. Differences were considered as statistically significant at
P  0.05. The animals used for the glucose incorporation into lipid
and glucose oxidation analysis were different from the ones used in
the rest of the experiments.
RESULTS
Effects of EPA on leptin expression and secretion. Basal
leptin secretion over 96 h was increased by incubation of
adipocytes with EPA at 10, 100, and 200 M compared with
control (43.8  21.0%, P  0.05; 71.1  24.5%, P 
0.01; and 73.7  25.6%, P  0.01 for 10, 100, and 200 M,
respectively) (Fig. 1A). An increase in leptin secretion was
observed from 48 h of treatment (data not shown). As ex-
pected, 1.6 nM insulin induced a highly significant increase of
leptin secretion (55.6  9.3%, P  0.001). The stimulatory
effect of EPA on insulin-stimulated leptin secretion was
present but less pronounced than that observed in the absence
of insulin (26.7  7.9% for 100 M, P  0.05; and 18 
9.1% for 200 M, P  0.05) (Fig. 1B).
The patterns of EPA’s effects on leptin expression at 96 h of
treatment were similar to those observed for leptin secretion.
Basal leptin mRNA expression was increased during incuba-
tion with EPA at 100 and 200 M, and insulin-stimulated
leptin expression was increased by EPA at the 200 M con-
centration (Fig. 2).
Effects of EPA on glucose utilization. EPA increased basal
glucose utilization, an effect that was observed from the first
24 h of treatment (data not shown). The increase over 96 h
(Fig. 3A) was statistically significant at the highest concentra-
tion tested, 200 M (50  15.7%, P  0.05), and was
strongly related to the increase observed in leptin secretion at
96 h (r0.89, P 0.01) (Fig. 3B). As expected, insulin (1.6
nM) significantly increased glucose uptake (179.7  52.1%,
P  0.001). However, EPA did not further increase insulin-
stimulated glucose utilization, and the EPA-induced increase in
insulin-stimulated leptin secretion was not related to glucose
uptake (r  0.12, not significant).
Effects of EPA on lactate production. Basal lactate produc-
tion by adipocytes incubated with EPA at 100 and 200 M was
significantly decreased at 96 h (25.9  6.4%, P  0.05;
36.8 10.6%, P 0.01, respectively). Insulin (1.6 nM) also
decreased lactate production, and the cotreatment with EPA
with insulin at the two highest concentrations, 100 and 200
M, produced a further decrease in lactate production (Fig.
4A). The proportion of glucose carbon metabolized to and
released as lactate over 96 h was decreased by EPA at the
highest concentration (200 M) in both the presence and
absence of insulin (Fig. 4B). This effect of EPA on the
anaerobic utilization of glucose was observed from 48 h of
treatment (data not shown). Furthermore, as shown in Fig. 4, C
and D, both basal (r  0.93, P  0.001) and insulin-
stimulated (r  0.84, P  0.01) increases of leptin secretion
were inversely related to lactate production.
Effects of EPA on glucose oxidation. EPA (200 M) and
insulin (1.6 nM) by themselves significantly increased (P 
0.05) the percentage of glucose oxidized to CO2. This increase
induced by EPA on glucose oxidation was not observed in the
presence of insulin (Fig. 5).
Effects of EPA on lipogenesis. The amount of glucose
incorporated into triglyceride was decreased by 200 M EPA
(28.0  5.9%, P  0.01). As expected, insulin significantly
Fig. 1. Effects of different concentrations of eicosapentaenoic acid (EPA) on
basal (A) and insulin-stimulated (B) leptin secretion by isolated rat adipocytes
over 96 h in culture. Results (media  SE) are representative of 10 indepen-
dent experiments. *P  0.05, **P  0.01, ***P  0.001 vs. control cells;
aP  0.05 vs. insulin alone-treated adipocytes.
Fig. 2. Effects of different concentrations of
EPA on basal and insulin-stimulated leptin
mRNA expression, as assessed by Northern
blots. Expression level of 18S ribosomal
RNA was determined and used as an internal
control to correct for minor variations in
total RNA amount. Results are representa-
tive of at least 2 independent experiments.
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increased glucose incorporation into triglyceride (467.7 
79.8%, P  0.01); however, the proportion (percentage) of
glucose incorporated into triglyceride of the total 96-h glucose
utilization was not increased by insulin (Table 1). Treatment
with 200 M EPA in the presence of insulin significantly
decreased the amount of glucose incorporated into triglyceride
(50.8  8.0%, P  0.01). In addition, the percentage of
glucose utilized that was incorporated into triglyceride was
significantly decreased by 200 M EPA in the absence but not
in the presence of insulin (Table 1).
Effects of EPA on lipolysis. The effects of EPA on basal
lipolysis were evaluated by determining the amount of glycerol
released into the media over 96 h of culture. EPA (200 M) did
not significantly modify glycerol release.
DISCUSSION
Controversial results (inhibition or stimulation) regarding
the in vitro effects of EPA on leptin gene expression and
secretion have been previously reported (37, 47). In the present
study, we demonstrated a direct concentration-dependent effect
of EPA to increase basal leptin secretion and gene expression
in cultured primary rat adipocytes. These results are in agree-
ment with the report by Murata et al. (37) in which EPA
induced a time- and dose-dependent increase of leptin mRNA
expression and leptin secretion in 3T3-L1 cells. Several in vivo
studies in rats and mice have reported that prolonged intake of
diets high in n-3 PUFAs resulted in significant decreases in
plasma leptin (22, 47). However, the direct effects of EPA to
increase leptin expression and secretion suggest that the de-
crease of circulating leptin concentrations reported in animals
consuming n-3 fatty acids are likely to be secondary to de-
creases observed in white fat adipose mass.
EPA also modestly increased leptin secretion and expression
in the presence of insulin. However, Cammisotto et al. (8)
reported an inhibitory effect of EPA on insulin-stimulated
leptin secretion in white adipocytes. The disparity may be
related to differences in the duration of the cultures (2 h vs.
96 h), the type of culture system employed (free floating vs.
Fig. 3. A: effects of EPA on basal and insulin-stimulated glucose utilization by
isolated rat adipocytes over 96 h in culture. Data are means  SE of 8
independent experiments. B: relationship between change in basal glucose
utilization and percent change of leptin production induced by 200 M EPA
compared with control over 96 h of culture. *P  0.05, ***P  0.001 vs.
control (non-EPA- or non-insulin-treated cells).
Fig. 4. Effects of EPA on lactate production
(A) and percentage of glucose carbon re-
leased as lactate (B) in absence and presence
of 1.6 nM insulin by adipocytes over 96 h in
culture. Data are means  SE of 8 indepen-
dent experiments. Also shown are the rela-
tionships between change in lactate produc-
tion and percent change of leptin production
induced by 200 M EPA compared with
control over 96 h of culture in absence (C)
and presence (D) of 1.6 nM insulin. *P 
0.05, **P  0.01, ***P  0.001 vs. control.
aP  0.05 and bP  0.01 vs. insulin alone
treated cells.
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collagen fixed) (34), the concentration of insulin (10 nM vs. 1.6
nM), and the concentrations of EPA (1 mM vs. 200 M). As
reported by Murata et al. (37), 100 M EPA is comparable to
its plasma concentrations after intake of dietary EPA. These
authors also demonstrated that 1 mM EPA was less potent than
100 M EPA in its effect to increase basal leptin secretion and
expression in 3T3-L1 cells (37).
The results of the present study suggest that there are
similarities in the effects of EPA and insulin to stimulate leptin
expression and secretion. First, EPA is more effective in
increasing basal leptin secretion than it is in the presence of
insulin, suggesting that insulin has already activated some of
the signaling pathways activated by EPA. Furthermore, both
insulin and EPA increase glucose utilization, decrease anaer-
obic metabolism of glucose to lactate, and increase glucose
oxidation. Finally, the actions of both insulin and EPA to
increase leptin production are highly correlated with their
effects to decrease anaerobic glucose metabolism to lactate
[present results and Mueller et al. (34)]. EPA has been shown
to activate intracellular insulin signaling pathways in hepatoma
cells (36). EPA treatment for 24 h stimulated tyrosine phos-
phorylation of insulin receptor substrate-1, binding of phos-
phatidylinositol 3-kinase to insulin receptor substrate-1, and
Akt kinase activity and downregulated the amount of phos-
phoenolpyruvate carboxykinase mRNA expression. These in-
sulin-like actions (36) suggest that EPA and insulin might
share and compete for a common intracellular pathway.
We have demonstrated (31, 34) along with others (57) that
insulin-stimulated glucose metabolism rather than insulin per
se is a major determinant of leptin production in both rodents
and humans. In fact, leptin secretion by cultured adipocytes is
more sensitive to the amount of glucose utilized during the
culture period than to the extracellular insulin concentration. A
previous study has demonstrated that dietary fish oil increased
GLUT4 (insulin-dependent glucose transport) gene expression
levels in skeletal muscle (32). In the present study, we ob-
served that 200 M EPA induced an increase in adipocyte
basal glucose uptake and that there was a strong relationship
between basal glucose utilization and leptin production in 200
M EPA-treated cells. These results suggest that increased
glucose uptake could contribute to the actions of EPA to
stimulates leptin production. However, the EPA-induced in-
creases of leptin secretion were not related to changes of
glucose uptake in the presence of insulin, suggesting that
glucose uptake per se is not the main determinant of the effects
of EPA. Our previous report (30) showed that glucose transport
is not a regulatory step in leptin production by adipocytes.
Rather, glucose transport is necessary for glucose to be further
metabolized. Inhibitors of glucose metabolism inhibit insulin-
stimulated leptin secretion in a concentration-dependent man-
ner (34). In addition, the 	3-adrenergic agonist Trecadrine,
which stimulates adipocyte glucose uptake, inhibits leptin
secretion (30). Thus we have also reported that the metabolism
of glucose beyond pyruvate is involved in the action of glucose
and insulin to stimulate leptin secretion (35). Mueller et al. (35)
showed that leptin secretion is inversely related to the propor-
tion of glucose that is metabolized to lactate. In fact, met-
formin, an antidiabetic drug that stimulates adipocyte glucose
uptake, appears to inhibit leptin secretion by increasing the
anaerobic metabolism of glucose to lactate (35). Our data
showed that EPA decreases lactate production by isolated
adipocytes and therefore the percentage of glucose carbon
released as lactate, suggesting that the increase in basal leptin
production by EPA is mediated, at least in part, by a decrease
in anaerobic glucose metabolism.
Compared with the basal state, the effects of EPA on
insulin-stimulated leptin secretion and expression and inhibi-
tory effects on lactate production were more modest. A possi-
ble explanation for the lack of synergetic or additive effects of
EPA in the presence of insulin is that adipocyte glucose
metabolism was already markedly increased by insulin; thus
EPA was only able to induce smaller additional effects on
adipocyte metabolism and leptin production. However, al-
though the effects of cotreatment with insulin and EPA on
lactate production were lower than in the absence of insulin,
they were still significant. Indeed, the increase on insulin-
stimulated leptin secretion by 200 M EPA was strongly
related to the measured decrease of lactate production, further
supporting the hypothesis that the decreased anaerobic metab-
olism of glucose to lactate is a major contributor to the actions
of EPA to increase leptin secretion.
Fig. 5. Effects of EPA on glucose oxidation as determined by the proportion
of 14C-labeled glucose metabolized to CO2. Data are means  SE of 4
independent experiments. Results were determined in cultured cells obtained
from different animals than used for the other parameters. *P  0.05 vs.
control cells (non-EPA- or non-insulin-treated cells).
Table 1. Effects of EPA on lipid metabolism in absence and presence of 1.6 nM insulin
Insulin (1.6 nM)
0 M EPA 200 M EPA 0 M EPA 200 M EPA
Lipogenesis,* nmol Glu/mg TG (n  6) 51.33.3 37.34.7‡ 281.331.6‡ 136.522.5†§
Glucose to TG,* % (n  6) 32.43.1 18.43.5† 30.33.8 26.61.4
Glycerol, mmol (n  8) 1,107.0182.9 1,331.0288.5
Values are means  SE; n  no. of experiments. EPA, eicosapentaenoic acid. Lipogenesis [assessed as amount and percentage of glucose (Glu) carbon
incorporated into triglyceride (TG)] and lipolysis (assessed as the amount of glycerol released to the media) were analyzed over 96 h in culture. *Determined
in cultured cells obtained from different animals than used for the other parameters. †P 0.05, ‡P 0.01 vs. corresponding control. §P 0.01 vs. insulin-treated
cells.
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Furthermore, our previous studies (18, 35) also suggest that
glucose utilization stimulates leptin production by directing the
metabolism of glucose to a fate other than anaerobic lactate
production, most likely to oxidation. In the present study, 200
M EPA increased the percentage of glucose that was oxidized
to CO2. These data suggest that the stimulatory effects of EPA
and insulin on basal leptin secretion and gene expression may
also involve an increase of glucose oxidation.
Finally, it has been suggested that n-3 PUFAs limit fat cell
hypertrophy in adipose tissue by decreasing lipogenesis and
increasing lipolysis by induction of hormone sensitive lipase
expression (43, 45). Our results indicate that EPA decreased
lipogenesis and induced a slight (nonsignificant) rise on basal
lipolysis. It is possible that these effects of EPA could be
secondary to the increase in leptin production, since leptin is
known to directly inhibit lipogenesis (46) and to stimulate
lipolysis in white adipose tissue (50).
In conclusion, we have demonstrated that EPA, like insulin,
stimulates leptin gene expression and secretion, and this effect
is strongly related to a decrease in the anaerobic conversion of
glucose to lactate. An increase in basal glucose uptake and
oxidation may also contribute to the effects of EPA on basal
leptin production. In addition, this increase in leptin production
may be responsible for the changes observed in lipogenesis.
Because, like EPA, leptin has multiple beneficial effects (both
systemic and local) on energy homeostasis and glucose (12, 16,
21, 41, 55), it is possible that some of described actions of EPA
to limit obesity and improve insulin sensitivity could be me-
diated indirectly via increased leptin production. Further ex-
periments are needed to better understand the molecular mech-
anism involved in EPA’s action on adipose tissue and their
relationship with insulin signaling and the endocrine function
of adipose tissue.
ACKNOWLEDGMENTS
The expert technical assistance of Ana Lorente and Vero´nica Cia´urriz is
gratefully acknowledged.
GRANTS
This work has been supported in part by the Government of Navarra
(Department of Education and Culture), the U.S.-Spain Science and Technol-
ogy Program 2000 (Fullbright 2000), Lı´nea Especial de Investigacio´n “Nutri-
cio´n, Salud y Obesidad” (University of Navarra), and National Institute of
Diabetes and Digestive and Kidney Diseases Grant DK-35747. P. Pe´rez-
Matute was supported by a doctoral grant from “Instituto Danone” (Spain).
REFERENCES
1. Ahren B, Mansson S, Gingerich RL, and Havel PJ. Regulation of
plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J
Physiol Regul Integr Comp Physiol 273: R113–R120, 1997.
2. Barr VA, Malide D, Zarnowski MJ, Taylor SI, and Cushman SW.
Insulin stimulates both leptin secretion and production by rat white
adipose tissue. Endocrinology 138: 4463–4472, 1997.
3. Belzung F, Raclot T, and Groscolas R. Fish oil n-3 fatty acids selectively
limit the hypertrophy of abdominal fat depots in growing rats fed high-fat
diets. Am J Physiol Regul Integr Comp Physiol 264: R1111–R1118, 1993.
4. Bergman RN and Mittelman SD. Central role of the adipocyte in insulin
resistance. J Basic Clin Physiol Pharmacol 9: 205–221, 1998.
5. Bottcher H and Furst P. Microcalorimetric and biochemical investiga-
tions of thermogenesis and metabolic pathways in human white adipo-
cytes. Int J Obes Relat Metab Disord 20: 874–881, 1996.
6. Bray GA, Lovejoy JC, Smith SR, DeLany JP, Lefevre M, Hwang D,
Ryan DH, and York DA. The influence of different fats and fatty acids
on obesity, insulin resistance and inflammation. J Nutr 132: 2488–2491,
2002.
7. Bray GA and Popkin BM. Dietary fat intake does affect obesity! Am J
Clin Nutr 68: 1157–1173, 1998.
8. Cammisotto PG, Gelinas Y, Deshaies Y, and Bukowiecki LJ. Regula-
tion of leptin secretion from white adipocytes by free fatty acids. Am J
Physiol Endocrinol Metab 285: E521–E526, 2003.
9. Carroll KK. Biological effects of fish oils in relation to chronic diseases.
Lipids 21: 731–732, 1986.
10. Connor WE. Importance of n-3 fatty acids in health and disease. Am J
Clin Nutr 71: 171S-175S, 2000.
11. Folch I, Lees M, and Sloane-Stanley GH. A simple method for the
isolation and purification of total lipids from animal tissue. J Biol Chem
193: 497–509, 1957.
12. Gorden P and Gavrilova O. The clinical uses of leptin. Curr Opin
Pharmacol 3: 655–659, 2003.
13. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in
humans: a critical review. J Lipid Res 30: 785–807, 1989.
14. Havel PJ. Leptin production and action: relevance to energy balance in
humans. Am J Clin Nutr 67: 355–356, 1998.
15. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms
regulating leptin production and energy balance. Proc Nutr Soc 59:
359–371, 2000.
16. Havel PJ. Update on adipocyte hormones: regulation of energy balance
and carbohydrate/lipid metabolism. Diabetes 53, Suppl 1: S143–151,
2004.
17. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL,
and Stern JS. Relationship of plasma leptin to plasma insulin and
adiposity in normal weight and overweight women: effects of dietary fat
content and sustained weight loss. J Clin Endocrinol Metab 81: 4406–
4413, 1996.
18. Havel PJ, Stanhope KL, Moreno-Aliaga MJ, Kras KM, and Evans J.
Potential role for mitochondrial metabolism in regulating leptin produc-
tion by cultured rat adipocytes. Obes Res 7, Suppl 1: 63S, 1999.
19. Havel PJ, Townsend R, Chaump L, and Teff K. High-fat meals reduce
24-h circulating leptin concentrations in women. Diabetes 48: 334–341,
1999.
20. Hu FB, van Dam RM, and Liu S. Diet and risk of Type II diabetes: the
role of types of fat and carbohydrate. Diabetologia 44: 805–817, 2001.
21. Huan JN, Li J, Han Y, Chen K, Wu N, and Zhao AZ. Adipocyte-
selective reduction of the leptin receptors induced by antisense RNA leads
to increased adiposity, dyslipidemia, and insulin resistance. J Biol Chem
278: 45638–45650, 2003.
22. Hun CS, Hasegawa K, Kawabata T, Kato M, Shimokawa T, and
Kagawa Y. Increased uncoupling protein 2 mRNA in white adipose
tissue, and decrease in leptin, visceral fat, blood glucose, and cholesterol
in KK-Ay mice fed with eicosapentaenoic and docosahexaenoic acids in
addition to linolenic acid. Biochem Biophys Res Commun 259: 85–90,
1999.
23. Jho DH, Cole SM, Lee EM, and Espat NJ. Role of omega-3 fatty acid
supplementation in inflammation and malignancy. Integr Cancer Ther 3:
98–111, 2004.
24. Jump DB and Clarke SD. Regulation of gene expression by dietary fat.
Annu Rev Nutr 19: 63–90, 1999.
25. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, and
Storlien LH. Development of muscle insulin resistance after liver insulin
resistance in high-fat-fed rats. Diabetes 40: 1397–1403, 1991.
26. Landt M, Gingerich RL, Havel PJ, Mueller WM, Schoner B, Hale JE,
and Heiman ML. Radioimmunoassay of rat leptin: sexual dimorphism
reversed from humans. Clin Chem 44: 565–570, 1998.
27. Luo J, Rizkalla SW, Boillot J, Alamowitch C, Chaib H, Bruzzo F,
Desplanque N, Dalix AM, Durand G, and Slama G. Dietary (n-3)
polyunsaturated fatty acids improve adipocyte insulin action and glucose
metabolism in insulin-resistant rats: relation to membrane fatty acids. J
Nutr 126: 1951–1958, 1996.
28. Minami A, Ishimura N, Sakamoto S, Takishita E, Mawatari K, Okada
K, and Nakaya Y. Effect of eicosapentaenoic acid ethyl ester v. oleic
acid-rich safflower oil on insulin resistance in type 2 diabetic model rats
with hypertriacylglycerolaemia. Br J Nutr 87: 157–162, 2002.
29. Moreno-Aliaga MJ, Lamas O, Marti A, and Martinez JA. Effects of a
beta3-adrenergic agonist on glucose uptake and leptin expression and
secretion in cultured adipocytes from lean and overweight (cafeteria) rats.
Biochem Biophys Res Commun 291: 1201–1207, 2002.
30. Moreno-Aliaga MJ, Martinez JA, Stanhope KL, Fernandez-Otero
MP, and Havel PJ. Effects of Trecadrine, a 	3-adrenergic agonist, on
R1687EPA ACTION ON LEPTIN AND GLUCOSE METABOLISM
AJP-Regul Integr Comp Physiol • VOL 288 • JUNE 2005 • www.ajpregu.org
 o
n
 M
ay 24, 2005 
ajpregu.physiology.org
D
ow
nloaded from
 
leptin secretion, glucose and lipid metabolism in isolated rat adipocytes.
Int J Obes Relat Metab Disord 26: 912–919, 2002.
31. Moreno-Aliaga MJ, Stanhope KL, and Havel PJ. Transcriptional reg-
ulation of the leptin promoter by insulin-stimulated glucose metabolism in
3T3-L1 adipocytes. Biochem Biophys Res Commun 283: 544–548, 2001.
32. Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N, Ikeda
Y, Nobukata H, Ishikawa T, and Shibutani Y. Influence of highly
purified eicosapentaenoic acid ethyl ester on insulin resistance in the
Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-
insulin-dependent diabetes mellitus. Metabolism 46: 1458–1464, 1997.
33. Mori Y, Murakawa Y, Yokoyama J, Tajima N, Ikeda Y, Nobukata H,
Ishikawa T, and Shibutani Y. Effect of highly purified eicosapentaenoic
acid ethyl ester on insulin resistance and hypertension in Dahl salt-
sensitive rats. Metabolism 48: 1089–1095, 1999.
34. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM,
Warden CH, Stern JS, and Havel PJ. Evidence that glucose metabolism
regulates leptin secretion from cultured rat adipocytes. Endocrinology
139: 551–558, 1998.
35. Mueller WM, Stanhope KL, Gregoire F, Evans JL, and Havel PJ.
Effects of metformin and vanadium on leptin secretion from cultured rat
adipocytes. Obes Res 8: 530–539, 2000.
36. Murata M, Kaji H, Iida K, Okimura Y, and Chihara K. Dual action of
eicosapentaenoic acid in hepatoma cells: up-regulation of metabolic action
of insulin and inhibition of cell proliferation. J Biol Chem 276: 31422–
31428, 2001.
37. Murata M, Kaji H, Takahashi Y, Iida K, Mizuno I, Okimura Y, Abe
H, and Chihara K. Stimulation by eicosapentaenoic acids of leptin
mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro.
Biochem Biophys Res Commun 270: 343–348, 2000.
38. Nobukata H, Ishikawa T, Obata M, and Shibutani Y. Long-term
administration of highly purified eicosapentaenoic acid ethyl ester pre-
vents diabetes and abnormalities of blood coagulation in male WBN/Kob
rats. Metabolism 49: 912–919, 2000.
39. Nordoy A, Marchioli R, Arnesen H, and Videbaek J. n-3 Polyunsatu-
rated fatty acids and cardiovascular diseases. Lipids Suppl 36: S127–S129,
2001.
40. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, and Kraegen EW.
Mechanisms of liver and muscle insulin resistance induced by chronic
high-fat feeding. Diabetes 46: 1768–1774, 1997.
41. Orci L, Cook WS, Ravazzola M, Wang MY, Park BH, Montesano R,
and Unger RH. Rapid transformation of white adipocytes into fat-
oxidizing machines. Proc Natl Acad Sci USA 101: 2058–2063, 2004.
42. Parrish CC, Pathy DA, and Angel A. Dietary fish oils limit adipose
tissue hypertrophy in rats. Metabolism 39: 217–219, 1990.
43. Parrish CC, Pathy DA, Parkes JG, and Angel A. Dietary fish oils
modify adipocyte structure and function. J Cell Physiol 148: 493–502,
1991.
44. Perez C, Fernandez-Galaz C, Fernandez-Agullo T, Arribas C, Andres
A, Ros M, and Carrascosa JM. Leptin impairs insulin signaling in rat
adipocytes. Diabetes 53: 347–353, 2004.
45. Raclot T, Groscolas R, Langin D, and Ferre P. Site-specific regulation
of gene expression by n-3 polyunsaturated fatty acids in rat white adipose
tissues. J Lipid Res 38: 1963–1972, 1997.
46. Ramsay TG. Porcine leptin inhibits lipogenesis in porcine adipocytes. J
Anim Sci 81: 3008–3017, 2003.
47. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR,
Nenseter MS, Christiansen EN, and Drevon CA. Reduction of leptin
gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42:
743–750, 2001.
48. Riccardi G, Giacco R, and Rivellese AA. Dietary fat, insulin sensitivity
and the metabolic syndrome. Clin Nutr 23: 447–456, 2004.
49. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on
glucose metabolism and lipolysis. J Biol Chem 239: 375–380, 1964.
50. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin
WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, and Meier
CA. Direct effects of leptin on brown and white adipose tissue. J Clin
Invest 100: 2858–2864, 1997.
51. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth
and development. Am J Clin Nutr 54: 438–463, 1991.
52. Stanhope KL, Moreno-Aliaga MJ, Kras KM, and Havel PJ. Assess-
ment of lipogenesis in long-term cultured rat adipocytes (Abstract). Obes
Res 7: 74S, 1999.
53. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, and
Pascoe WS. Fish oil prevents insulin resistance induced by high-fat
feeding in rats. Science 237: 885–888, 1987.
54. Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M,
Townsend RR, Keim NL, D’Alessio D, and Havel PJ. Dietary fructose
reduces circulating insulin and leptin, attenuates postprandial suppression
of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab
89: 2963–2972, 2004.
55. Unger RH. The hyperleptinemia of obesity-regulator of caloric surpluses.
Cell 117: 145–146, 2004.
56. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P,
Heinze E, Rascher W, Teller W, Tornqvist H, and Hauner H. Insulin
and cortisol promote leptin production in cultured human fat cells. Dia-
betes 45: 1435–1438, 1996.
57. Wellhoener P, Fruehwald-Schultes B, Kern W, Dantz D, Kerner W,
Born J, Fehm HL, and Peters A. Glucose metabolism rather than insulin
is a main determinant of leptin secretion in humans. J Clin Endocrinol
Metab 85: 1267–1271, 2000.
R1688 EPA ACTION ON LEPTIN AND GLUCOSE METABOLISM
AJP-Regul Integr Comp Physiol • VOL 288 • JUNE 2005 • www.ajpregu.org
 o
n
 M
ay 24, 2005 
ajpregu.physiology.org
D
ow
nloaded from
 
